vs
Side-by-side financial comparison of ARMSTRONG WORLD INDUSTRIES INC (AWI) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $388.3M, roughly 1.3× ARMSTRONG WORLD INDUSTRIES INC). ARMSTRONG WORLD INDUSTRIES INC runs the higher net margin — 16.9% vs 6.8%, a 10.0% gap on every dollar of revenue. On growth, ARMSTRONG WORLD INDUSTRIES INC posted the faster year-over-year revenue change (5.6% vs -1.7%). Over the past eight quarters, ARMSTRONG WORLD INDUSTRIES INC's revenue compounded faster (9.1% CAGR vs -0.1%).
Armstrong World Industries, Inc. is an international designer and manufacturer of wall and ceiling building materials based in Lancaster, Pennsylvania. As of 2014, AWI had 3,100 employees and a global manufacturing network of 17 facilities, down from 26, including nine plants dedicated to its WAVE joint venture, in 2012.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
AWI vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $388.3M | $493.8M |
| Net Profit | $65.5M | $33.7M |
| Gross Margin | 39.8% | — |
| Operating Margin | 23.7% | 9.9% |
| Net Margin | 16.9% | 6.8% |
| Revenue YoY | 5.6% | -1.7% |
| Net Profit YoY | 5.3% | 10.5% |
| EPS (diluted) | $1.51 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $388.3M | $493.8M | ||
| Q3 25 | $425.2M | $492.9M | ||
| Q2 25 | $424.6M | $468.8M | ||
| Q1 25 | $382.7M | $458.4M | ||
| Q4 24 | $367.7M | $502.4M | ||
| Q3 24 | $386.6M | $511.2M | ||
| Q2 24 | $365.1M | $504.3M | ||
| Q1 24 | $326.3M | $495.1M |
| Q4 25 | $65.5M | $33.7M | ||
| Q3 25 | $86.3M | $71.7M | ||
| Q2 25 | $87.8M | $39.3M | ||
| Q1 25 | $69.1M | $20.7M | ||
| Q4 24 | $62.2M | $30.5M | ||
| Q3 24 | $76.9M | $19.4M | ||
| Q2 24 | $65.9M | $-153.0M | ||
| Q1 24 | $59.9M | $4.0M |
| Q4 25 | 39.8% | — | ||
| Q3 25 | 42.0% | — | ||
| Q2 25 | 41.4% | — | ||
| Q1 25 | 39.2% | — | ||
| Q4 24 | 39.1% | — | ||
| Q3 24 | 42.4% | — | ||
| Q2 24 | 40.9% | — | ||
| Q1 24 | 38.1% | — |
| Q4 25 | 23.7% | 9.9% | ||
| Q3 25 | 27.6% | 13.8% | ||
| Q2 25 | 29.0% | 12.8% | ||
| Q1 25 | 25.7% | 7.0% | ||
| Q4 24 | 22.3% | 7.8% | ||
| Q3 24 | 28.8% | 6.6% | ||
| Q2 24 | 26.0% | -31.3% | ||
| Q1 24 | 26.4% | 3.2% |
| Q4 25 | 16.9% | 6.8% | ||
| Q3 25 | 20.3% | 14.5% | ||
| Q2 25 | 20.7% | 8.4% | ||
| Q1 25 | 18.1% | 4.5% | ||
| Q4 24 | 16.9% | 6.1% | ||
| Q3 24 | 19.9% | 3.8% | ||
| Q2 24 | 18.0% | -30.3% | ||
| Q1 24 | 18.4% | 0.8% |
| Q4 25 | $1.51 | $0.40 | ||
| Q3 25 | $1.98 | $0.84 | ||
| Q2 25 | $2.01 | $0.46 | ||
| Q1 25 | $1.58 | $0.24 | ||
| Q4 24 | $1.41 | $0.37 | ||
| Q3 24 | $1.75 | $0.23 | ||
| Q2 24 | $1.50 | $-1.84 | ||
| Q1 24 | $1.36 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $112.7M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $900.7M | $865.9M |
| Total Assets | $1.9B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $112.7M | $375.2M | ||
| Q3 25 | $90.1M | $340.1M | ||
| Q2 25 | $81.1M | $224.7M | ||
| Q1 25 | $82.8M | $99.0M | ||
| Q4 24 | $79.3M | $229.9M | ||
| Q3 24 | $73.7M | $103.8M | ||
| Q2 24 | $73.6M | $19.4M | ||
| Q1 24 | $69.6M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $900.7M | $865.9M | ||
| Q3 25 | $889.2M | $890.7M | ||
| Q2 25 | $837.8M | $833.8M | ||
| Q1 25 | $793.4M | $789.2M | ||
| Q4 24 | $757.1M | $764.9M | ||
| Q3 24 | $717.0M | $732.5M | ||
| Q2 24 | $669.0M | $706.5M | ||
| Q1 24 | $626.8M | $856.2M |
| Q4 25 | $1.9B | $2.2B | ||
| Q3 25 | $1.9B | $2.2B | ||
| Q2 25 | $1.9B | $2.1B | ||
| Q1 25 | $1.9B | $2.0B | ||
| Q4 24 | $1.8B | $2.2B | ||
| Q3 24 | $1.8B | $2.1B | ||
| Q2 24 | $1.8B | $2.0B | ||
| Q1 24 | $1.7B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $110.0M | $114.1M |
| Free Cash FlowOCF − Capex | $62.2M | — |
| FCF MarginFCF / Revenue | 16.0% | — |
| Capex IntensityCapex / Revenue | 12.3% | — |
| Cash ConversionOCF / Net Profit | 1.68× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $246.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $110.0M | $114.1M | ||
| Q3 25 | $122.9M | $137.3M | ||
| Q2 25 | $81.6M | $137.2M | ||
| Q1 25 | $41.0M | $-117.5M | ||
| Q4 24 | $86.6M | $133.0M | ||
| Q3 24 | $96.5M | $91.8M | ||
| Q2 24 | $57.3M | $107.0M | ||
| Q1 24 | $26.4M | $-125.2M |
| Q4 25 | $62.2M | — | ||
| Q3 25 | $100.3M | — | ||
| Q2 25 | $61.7M | — | ||
| Q1 25 | $21.9M | — | ||
| Q4 24 | $57.8M | — | ||
| Q3 24 | $77.1M | — | ||
| Q2 24 | $37.4M | — | ||
| Q1 24 | $11.7M | — |
| Q4 25 | 16.0% | — | ||
| Q3 25 | 23.6% | — | ||
| Q2 25 | 14.5% | — | ||
| Q1 25 | 5.7% | — | ||
| Q4 24 | 15.7% | — | ||
| Q3 24 | 19.9% | — | ||
| Q2 24 | 10.2% | — | ||
| Q1 24 | 3.6% | — |
| Q4 25 | 12.3% | — | ||
| Q3 25 | 5.3% | — | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | 7.8% | — | ||
| Q3 24 | 5.0% | — | ||
| Q2 24 | 5.5% | — | ||
| Q1 24 | 4.5% | — |
| Q4 25 | 1.68× | 3.39× | ||
| Q3 25 | 1.42× | 1.91× | ||
| Q2 25 | 0.93× | 3.49× | ||
| Q1 25 | 0.59× | -5.66× | ||
| Q4 24 | 1.39× | 4.36× | ||
| Q3 24 | 1.25× | 4.72× | ||
| Q2 24 | 0.87× | — | ||
| Q1 24 | 0.44× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AWI
| Distributors | $183.0M | 47% |
| Architectural Specialties | $143.7M | 37% |
| Home Centers | $27.2M | 7% |
| Retailers And Other | $21.7M | 6% |
| Direct Customers | $12.7M | 3% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
